TG THERAPEUTICS, INC. — Director's Dealing 2023

Sep 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2023-09-28

Reporting Person: Hoberman Kenneth (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-28	Common Stock	A	20000	—	Acquired	242685	Direct

Footnotes

F1: Reflects a grant of restricted shares that will vest on June 14, 2024.

F2: Includes shares of restricted Common Stock, which vest over various time periods.